Mou_2013_J.Virol_87_9379

Reference

Title : The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies - Mou_2013_J.Virol_87_9379
Author(s) : Mou H , Raj VS , van Kuppeveld FJ , Rottier PJ , Haagmans BL , Bosch BJ
Ref : J Virol , 87 :9379 , 2013
Abstract :

The spike (S) protein of the recently emerged human Middle East respiratory syndrome coronavirus (MERS-CoV) mediates infection by binding to the cellular receptor dipeptidyl peptidase 4 (DPP4). Here we mapped the receptor binding domain in the S protein to a 231-amino-acid fragment (residues 358 to 588) by evaluating the interaction of spike truncation variants with receptor-expressing cells and soluble DPP4. Antibodies to this domain--much less so those to the preceding N-terminal region--efficiently neutralize MERS-CoV infection.

PubMedSearch : Mou_2013_J.Virol_87_9379
PubMedID: 23785207

Related information

Citations formats

Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ (2013)
The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
J Virol 87 :9379

Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ (2013)
J Virol 87 :9379